Table of Contents

Select this article
- C F Semenkovich and
- J W Heinecke
The mystery of diabetes and atherosclerosis: time for a new plot.
Diabetes March 1997 46:327-334; doi:10.2337/diabetes.46.3.327
- Abstract
Select this article
- Q Wang,
- C Bing,
- K Al-Barazanji,
- D E Mossakowaska,
- X M Wang,
- D L McBay,
- W A Neville,
- M Taddayon,
- L Pickavance,
- S Dryden,
- M E Thomas,
- M T McHale,
- I S Gloyer,
- S Wilson,
- R Buckingham,
- J R Arch,
- P Trayhurn,
- and G Williams
Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.
Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335
- Abstract
Select this article
- C T Montague,
- J B Prins,
- L Sanders,
- J E Digby,
- and S O'Rahilly
Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.
Diabetes March 1997 46:342-347; doi:10.2337/diabetes.46.3.342
- Abstract
Select this article
- H Matsui,
- K Okumura,
- K Kawakami,
- M Hibino,
- Y Toki,
- and T Ito
Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides.
Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348
- Abstract
Select this article
- K Matsuda,
- E Araki,
- R Yoshimura,
- K Tsuruzoe,
- N Furukawa,
- K Kaneko,
- H Motoshima,
- K Yoshizato,
- H Kishikawa,
- and M Shichiri
Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells.
Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354
- Abstract
Select this article
- J A Pinies,
- Y Fu,
- J A Vazquez,
- and D Faustman
New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease.
Diabetes March 1997 46:363-371; doi:10.2337/diabetes.46.3.363
- Abstract
Select this article
- J Guan,
- P F Zucker,
- M T Behme,
- R Zhong,
- P Atkinson,
- and J Dupré
Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts.
Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372
- Abstract
Select this article
- J Radons,
- V Burkart,
- and H Kolb
MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
Diabetes March 1997 46:379-385; doi:10.2337/diabetes.46.3.379
- Abstract
Select this article
- J Ferrer,
- J Wasson,
- K D Schoor,
- M Mueckler,
- H Donis-Keller,
- and M A Permutt
Mapping novel pancreatic islet genes to human chromosomes.
Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386
- Abstract
Select this article
- T Brun,
- F Assimacopoulos-Jeannet,
- B E Corkey,
- and M Prentki
Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1.
Diabetes March 1997 46:393-400; doi:10.2337/diabetes.46.3.393
- Abstract
Select this article
- S L Gillison,
- S G Straub,
- and G W Sharp
The alpha2-adrenergic receptor is more effective than the galanin receptor in activating G-proteins in RINm5F beta-cell membranes.
Diabetes March 1997 46:401-407; doi:10.2337/diabetes.46.3.401
- Abstract
Select this article
- Y Lee,
- H Hirose,
- Y T Zhou,
- V Esser,
- J D McGarry,
- and R H Unger
Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.
Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408
- Abstract
Select this article
- J D Bagdade,
- D E Kelley,
- R R Henry,
- R H Eckel,
- and M C Ritter
Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
Diabetes March 1997 46:414-420; doi:10.2337/diabetes.46.3.414
- Abstract
Select this article
- A Basu,
- A Caumo,
- F Bettini,
- A Gelisio,
- A Alzaid,
- C Cobelli,
- and R A Rizza
Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421
- Abstract
Select this article
- M N Ghazzi,
- J E Perez,
- T K Antonucci,
- J H Driscoll,
- S M Huang,
- B W Faja,
- and R W Whitcomb
Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.
Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433
- Abstract
Select this article
- B Zinman,
- H Tildesley,
- J L Chiasson,
- E Tsui,
- and T Strack
Insulin lispro in CSII: results of a double-blind crossover study.
Diabetes March 1997 46:440-443; doi:10.2337/diabetes.46.3.440
- Abstract
Select this article
- W T Garvey,
- L Maianu,
- A Kennedy,
- P Wallace,
- E Ganaway,
- L L Hamacher,
- D P Yarnall,
- J M Lenhard,
- and D K Burns
Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition.
Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444
- Abstract
Select this article
- G S Hotamisligil,
- P Arner,
- R L Atkinson,
- and B M Spiegelman
Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.
Diabetes March 1997 46:451-455; doi:10.2337/diabetes.46.3.451
- Abstract
Select this article
- J B Albu,
- L Murphy,
- D H Frager,
- J A Johnson,
- and F X Pi-Sunyer
Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.
Diabetes March 1997 46:456-462; doi:10.2337/diabetes.46.3.456
- Abstract
Select this article
- T Higashi,
- H Sano,
- T Saishoji,
- K Ikeda,
- Y Jinnouchi,
- T Kanzaki,
- N Morisaki,
- H Rauvala,
- M Shichiri,
- and S Horiuchi
The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.
Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463
- Abstract
Select this article
- I S Park,
- H Kiyomoto,
- S L Abboud,
- and H E Abboud
Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Diabetes March 1997 46:473-480; doi:10.2337/diabetes.46.3.473
- Abstract
Select this article
- P Rossing,
- L Tarnow,
- S Boelskifte,
- B R Jensen,
- F S Nielsen,
- and H H Parving
Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481
- Abstract
Select this article
- K Fukuda,
- Y Ozaki,
- K Satoh,
- S Kume,
- M Tawata,
- T Onaya,
- K Sakurada,
- M Seto,
- and Y Sasaki
Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation.
Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488
- Abstract
Select this article
- T Hansen,
- C B Andersen,
- S M Echwald,
- S A Urhammer,
- J O Clausen,
- H Vestergaard,
- D Owens,
- L Hansen,
- and O Pedersen
Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index.
Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
- Abstract
Select this article
- H Inoue,
- J Ferrer,
- M Warren-Perry,
- Y Zhang,
- H Millns,
- R C Turner,
- S C Elbein,
- C L Hampe,
- B K Suarez,
- N Inagaki,
- S Seino,
- and M A Permutt
Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM.
Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502
- Abstract
Select this article
- L Hansen,
- S M Echwald,
- T Hansen,
- S A Urhammer,
- J O Clausen,
- and O Pedersen
Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM.
Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508
- Abstract
Select this article
- X S Wu-Peng,
- S C Chua, Jr,
- N Okada,
- S M Liu,
- M Nicolson,
- and R L Leibel
Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat.
Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513
- Abstract
Select this article
- G M Beattie,
- J H Crowe,
- A D Lopez,
- V Cirulli,
- C Ricordi,
- and A Hayek
Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage.
Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519
- Abstract
Select this article
- M Björnholm,
- Y Kawano,
- M Lehtihet,
- and J R Zierath
Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
Diabetes March 1997 46:524-527; doi:10.2337/diabetes.46.3.524
- Abstract
Select this article
- P J Kaisaki,
- S Menzel,
- T Lindner,
- N Oda,
- I Rjasanowski,
- J Sahm,
- G Meincke,
- J Schulze,
- H Schmechel,
- C Petzold,
- H M Ledermann,
- G Sachse,
- V V Boriraj,
- R Menzel,
- W Kerner,
- R C Turner,
- K Yamagata,
- and G I Bell
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.
Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528
- Abstract

Diabetes

The mystery of diabetes and atherosclerosis: time for a new plot.

Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.

Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides.

Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells.

New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease.

Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts.

MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.

Mapping novel pancreatic islet genes to human chromosomes.

Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1.

The alpha2-adrenergic receptor is more effective than the galanin receptor in activating G-proteins in RINm5F beta-cell membranes.

Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.

Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.

Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.

Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.

Insulin lispro in CSII: results of a double-blind crossover study.

Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition.

Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.

Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.

The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.

Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.

Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation.

Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index.

Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM.

Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM.

Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat.

Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage.

Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.

Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.

This Issue

Current Issue